Develop Diagnostics Suppliers In North America

Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and ...

Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...

For more than 50 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood ...

STEMart is an industry-leading eCommerce platform, with an expanded global footprint, we now have a broad portfolio of more than 10,000 products. In the fields of science, technology, and engineering, from the discovery stage towards the ...

DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services, including clinical trials and regulatory services, specializing in the development of custom assays, consumables, and instruments for point-of-use applications. ...

Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop ...

3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling ...

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine. Hemagen's mission is to offer high quality diagnostic test kits in user friendly formats. We continue to the highest quality gold standard test ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

Cognoptix is developing a simple, innovative, non-invasive beta amyloid eye scanning test for use in adult patients being evaluated for Alzheimer’s Disease to aid in early diagnosis of this complex and devastating ...

Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...

SA Scientific, Ltd. has proudly served clinical laboratories worldwide since 1984. We design, develop and manufacture a wide range of One-Step rapid tests for fertility and infectious diseases. SA Scientific has a tradition of producing excellent ...

An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells. CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic ...

ID Genomics is combating this threat by combining epidemiological surveillance, bioinformatics, and molecular diagnostics. Developing high performance personalized diagnostics. Our industry-leading team combines microbiology, biochemistry and ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...

ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...

Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients to help them personalize cancer treatment plans and improve patients’ quality of living. We started developing the ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ...

SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The ...